Superfine Needles Profile
Key Indicators
- Authorised Capital ₹ 1.10 M
as on 13-12-2024
- Paid Up Capital ₹ 1.05 M
as on 13-12-2024
- Company Age 36 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.22 M
as on 13-12-2024
- Revenue 34.28%
(FY 2022)
- Profit 716.57%
(FY 2022)
- Ebitda 56.84%
(FY 2022)
- Net Worth 15.72%
(FY 2022)
- Total Assets -4.95%
(FY 2022)
About Superfine Needles
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.10 M and a paid-up capital of Rs 1.05 M.
The company currently has active open charges totaling ₹6.22 M.
Bheeman Anand, Chandrasekhara Girijamba, and Nanjan Chandran serve as directors at the Company.
- CIN/LLPIN
U33112KA1988PTC009617
- Company No.
009617
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Nov 1988
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Superfine Needles Private Limited offer?
Superfine Needles Private Limited offers a wide range of products and services, including Scalpels, Needles & Scissors, Surgical Needles, Disposable Cannulas, IV Cannula, Aspiration Needles, Veterinary Instruments, Sutures, Non Absorbable Sutures, Suture Needle, Medical Laboratory Instruments.
Who are the key members and board of directors at Superfine Needles?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bheeman Anand  | Director | 22-May-2015 | Current |
| Chandrasekhara Girijamba | Director | 15-Jul-1998 | Current |
| Nanjan Chandran | Director | 26-Nov-1988 | Current |
Financial Performance of Superfine Needles.
Superfine Needles Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 34.28% increase. The company also saw a substantial improvement in profitability, with a 716.57% increase in profit. The company's net worth Soared by an impressive increase of 15.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Superfine Needles?
In 2021, Superfine Needles had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Electronica Finance Limited Creation Date: 19 Feb 2014 | ₹0.42 M | Open |
Indian Overseas Bank Creation Date: 22 Aug 2004 | ₹5.30 M | Open |
The Vysya Bank Ltd. Creation Date: 29 Jun 1990 | ₹0.50 M | Open |
How Many Employees Work at Superfine Needles?
Superfine Needles has a workforce of 4 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Superfine Needles, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Superfine Needles's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
